blog.globalmarketanalyst.com
Glioblastoma Multiforme – Cancer Immunotherapies Dominate First-in-Class Product Innovation
Glioblastoma, a particularly aggressive form of brain tumor, has a promising treatment pipeline, with 120 first-in-class programs acting on 86 first-in-class molecular targets. The glioblastoma the…